Reviva Pharmaceuticals Holdings Inc — Cash Flow (NASDAQ:RVPH) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics Dividends

Quarterly Annual

Cash from operating activities 3.73 M-10.67 M-18.96 M-28.32 M-33.54 M -27.9 M Cash from investing activities ————— — Cash from financing activities 12.49 M31.6 M7.79 M33.17 M23.65 M 35.52 M Free cash flow 3.73 M-10.67 M-18.96 M-28.32 M-33.54 M -27.9 M

Haberler

Estudio de biomarcadores vocales respalda la eficacia de brilaroxazina en esquizofrenia

Vocal biomarker study supports brilaroxazine’s efficacy in schizophrenia

Chardan Capital asume cobertura de acciones de Reviva Pharmaceuticals con calificación de Compra

Chardan Capital asume cobertura de Reviva Pharmaceuticals con calificación de Compra

Chardan Capital assumes coverage on Reviva Pharmaceuticals stock with Buy rating

Vanguard Total Stock Market ETF (VTI) Daily Snapshot—12/30/25 - TipRanks.com

H.C. Wainwright reitera calificación de Compra para Reviva Pharmaceuticals

H.C. Wainwright reitera calificación de Compra para acciones de Reviva Pharmaceuticals

Reviva Pharmaceuticals stock rating reiterated at Buy by H.C. Wainwright

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.16%

Las bolsas de valores de Estados Unidos cerraron con subidas; el Dow Jones Industrial Average ganó un 0.16%

Las acciones de Reviva Pharmaceuticals se desploman tras la solicitud de la FDA de un segundo ensayo de Fase 3